HBV HDV COMBINATION THERAPY OF HBV AND HDV INFECTION

摘要

The present invention Na + - tau to call acid co transport for inhibitors and nucleoside analogs, such as lamivudine, telbivudine or entecavir, nucleotide analog, for example, of a polypeptide (NTCP) tenofovir Birr, Oh depot builder, and immunomodulators, e.g., provides a composition comprising an active ingredient selected from the group consisting of interferon alpha. NTCP inhibitor inhibits the penetration of in the HBV / HDV cells, preferably derived from HBV pre-S1 peptide. A method for treating HBV and HDV infections, B-type and D hepatitis, and chronic hepatitis B and D are also provided.